Lorenzo Rinaldo1, Sarah Chao Ying Xu1, Scott D Eggers2, Diva R Salomão3,4, John J Chen3,2, Aditya Raghunathan4. 1. Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA. 2. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 3. Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA. 4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Abstract
PURPOSE: Tumors previously diagnosed as solitary fibrous tumors (SFT) and hemangiopericytomas (HPC) are characterized by the NAB2-STAT6 fusion gene, leading to nuclear STAT6 expression, and are now considered part of one SFT/HPC tumor entity by the 2016 World Health Organization Classification of Tumors of the Central Nervous System. We present the first primary choroidal SFT/HPC with the diagnosis confirmed by STAT6 expression. PROCEDURES: A 51-year-old man underwent enucleation for a choroidal mass, which revealed a spindle cell neoplasm involving the optic nerve, without extrascleral extension. Immunohistochemical stains for S-100, melan-A, tyrosinase, and HMB45 were all negative; however, detection of monosomy 3 by FISH favored a choroidal spindle cell melanoma. Four years later, he presented with hepatic metastases of a spindle cell tumor, and a year later with an epithelioid malignancy involving the calvarium. RESULTS: The calvarial tumor showed nuclear STAT6 immunoreactivity, supporting the diagnosis of SFT/HPC. Retrospectively, the choroidal and hepatic masses were also found to demonstrate nuclear STAT6 expression, supporting the diagnosis of a primary choroidal SFT/HPC with metachronous metastases to the liver and calvarium. CONCLUSIONS: This case highlights the significance of considering SFT/HPC in the diagnosis of intraocular spindle cell tumors and the importance of STAT6 immunohistochemistry in the evaluation of such tumors.
PURPOSE: Tumors previously diagnosed as solitary fibrous tumors (SFT) and hemangiopericytomas (HPC) are characterized by the NAB2-STAT6 fusion gene, leading to nuclear STAT6 expression, and are now considered part of one SFT/HPC tumor entity by the 2016 World Health Organization Classification of Tumors of the Central Nervous System. We present the first primary choroidal SFT/HPC with the diagnosis confirmed by STAT6 expression. PROCEDURES: A 51-year-old man underwent enucleation for a choroidal mass, which revealed a spindle cell neoplasm involving the optic nerve, without extrascleral extension. Immunohistochemical stains for S-100, melan-A, tyrosinase, and HMB45 were all negative; however, detection of monosomy 3 by FISH favored a choroidal spindle cell melanoma. Four years later, he presented with hepatic metastases of a spindle cell tumor, and a year later with an epithelioid malignancy involving the calvarium. RESULTS: The calvarial tumor showed nuclear STAT6 immunoreactivity, supporting the diagnosis of SFT/HPC. Retrospectively, the choroidal and hepatic masses were also found to demonstrate nuclear STAT6 expression, supporting the diagnosis of a primary choroidal SFT/HPC with metachronous metastases to the liver and calvarium. CONCLUSIONS: This case highlights the significance of considering SFT/HPC in the diagnosis of intraocular spindle cell tumors and the importance of STAT6 immunohistochemistry in the evaluation of such tumors.
Authors: Willem Maat; Ekaterina S Jordanova; Shama L van Zelderen-Bhola; Ed R Barthen; Hans W Wessels; Nicoline E Schalij-Delfos; Martine J Jager Journal: Arch Pathol Lab Med Date: 2007-01 Impact factor: 5.534
Authors: Min S Park; Shreyaskumar R Patel; Joseph A Ludwig; Jonathan C Trent; Charles A Conrad; Alexander J Lazar; Wei-Lien Wang; Piyaporn Boonsirikamchai; Haesun Choi; Xuemei Wang; Robert S Benjamin; Dejka M Araujo Journal: Cancer Date: 2011-04-08 Impact factor: 6.860
Authors: Lucy I Mudie; E Lacey Echalier; Matthew A Powers; Ahmed Gilani; Ryan D Larochelle; Scott C N Oliver; Sophie D Liao Journal: Am J Ophthalmol Case Rep Date: 2022-04-10